37 consecutive , previously untreated patients with advanced multiple myeloma ( 16 patients stage ii , 21 patients stage iii ) were treated with a five drug regimen consisting of carmustine , melphalan , vincristine , cyclophosphamide and prednisolone ( m-2-protocol ) in a prospective manner .
C0026764
multiple myeloma
C0010583
cyclophosphamide